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Abstract
Meningioangiomatosis is a rare hamartomatous lesion or meningiovascular malformation in brain. In extremely rare 
condition, meningioma may occur together with meningioangiomatosis, and only 19 cases have been described in 
English literature until now. We now report a case of meningioangiomatosis-associated meningioma with atypical and 
clear cell variant. A 34-year-old man presented a 3-month history of progressive numbness and weakness of his left 
lower extremity. He had no stigmata of neurofibromatosis type 2. Magnetic resonance imaging (MRI) revealed 
multifocal lesions in the right frontoparietal lobe. The lesions were totally removed. Microscopically, parts of lesions 
were atypical and clear cell meningioma corresponding to WHO grade II. The adjacent brain parenchyma showed the 
histological features of meningioangiomatosis. Neoplastic cells in atypical meningioma area were immunoreactive to 
epithelial membrane antigen (EMA) with high MIB-1 index of up to 20%. However, the spindle cells in 
meningioangiomatosis area were negative for EMA with low MIB-1 index of up to 1%. The diagnosis of atypical 
meningioma associated with sporadic meningioangiomatosis was made. To our knowledge, this is the first case of a 
meningioangiomatosis-associated meningioma with atypical and clear cell variant component to be described. The 
patient had been followed-up for 11 months without adjuvant radiotherapy or chemotherapy. No tumor recurrence 
was found during this period. Meningioangiomatosis-associated meningioma is more likely to occur in younger 
patients and histologically to mimic parenchymal invasion of brain. We suggest that postoperative radiotherapy or 
chemotherapy should be given careful consideration to avoid over-treatment due to erroneously interpret as 
malignant meningioma.
Background
Meningioangiomatosis is a rare meningiovascular mal-
formation in the central nervous system, which is charac-
terized by a plaque-like or nodular mass within the
cerebral cortex and overlying leptomeninges in the
patients with intractable seizures. Meningioangiomatosis
may occur either sporadically or occur in patients with
neurofibromatosis type 2 (NF2). Sporadic meningioan-
giomatosis usually presents seizures and persistent head-
aches. NF2-associated meningioangiomatosis is often
asymptomatic and diagnosed only at autopsy [1]. Histo-
logically, the lesion typically presents perivascular prolif-
eration of meningiothelial and fibroblast-like cells,
entrapped glial islands and focal calcification. In
extremely rare condition, meningioma may occur
together with meningioangiomatosis, and only 19 cases
have been described in English literature until now [2-
14]. Herein, we report a case of meningioma associated
with sporadic meningioangiomatosis occurred in a mid-
dle-aged man. In contrast to most meningioangiomato-
sis-associated meningiomas exhibited bland cytological
features and corresponding to WHO grade I, our case
presented a characteristic of atypical and clear cell men-
ingioma component corresponding to WHO grade II. To
our knowledge, this is the first report of meningioan-
giomatosis-associated meningioma with atypical and
clear cell variants.
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Case presentation
A 34-year-old Chinese man presented a 3-month history
of progressive numbness and weakness of his left lower
extremity, and which had increased in severity over the
past 2 weeks. Epileptic fits or neurological deficits were
not recorded. On physical examination, the patient had
mild weakness on his left lower extremity. Sensory exam-
ination revealed that hypoalgesia could be detected in the
area below the left knee. Neurological examinations
showed no abnormality in cranial nerves, and no defect
was disclosed by the visual field test. The patient had no
family history of neurofibromatosis, and no stigmata of
NF2 including acoustic schwannomas or masses of the
spinal cord was found by neuroimaging examination.
Magnetic resonance imaging (MRI) revealed multiple
hypointense lesions in the right frontoparietal lobe with
heterogeneous contrast enhancement after Gd-diethylen-
etriamine pentaacetic acid administration (Figure 1).
Fluid attenuated inversion recovery (FLAIR) demon-
strated predominantly gyriform hyperintensity and lep-
tomeinges. The patient underwent a right frontal
craniotomy. A well-demarcated ovoid mass with multiple
yellow firm granulations scattered on the cortical surface
was totally removed. On macroscopical examination, part
of lesion tissue appeared grayish and moderately firm
with smaller tissue fragments of variable sizes. The whit-
ish and slightly hard ovoid mass, measuring 3.0 cm in
diameter, was well-demarcated without fibrous capsule
and gross calcification. Neither necrosis nor haemor-
rhage was found in the mass and other tissue fragments
(Figure 2).
It was found the removed whitish mass was composed
of collagen bundles and spindle tumor cells forming small
whorls and syncytial structures when examined under
the light microscope. Focal hypercellularity and higher
mitotic activity were noted. Necrosis and haemorrhage
were not observed, but up to 6 mitotic figures of tumor
cells per 10 high power fields were detected in these areas
(Figure 3a). These histopathological findings were consis-
tent with atypical meningioma. In some areas, the mass
was mainly composed of clear cells resembling the classi-
cal histological feature of clear cell meningioma with
small round monomorphic nuclei and abundant clear
cytoplasm. Neither mitosis nor necrotic areas were seen
(Figure 3b). The adjacent brain parenchyma to the mass
and other removed smaller grayish lesion revealed
numerous abnormal small intracortical blood vessels,
which were cuffed by meningothelial or fibroblast-like
spindle cells (Figure 3c). The spindle cells showed bland
nuclei and elongated cytoplasm with indistinct cell bor-
ders. Neither necrosis nor mitotic activity was found. Gli-
osis was observed in the intervening brain parenchyma.
The gradual transition from perivascular proliferation of
spindle cells to the mass of the meningioma could be
observed (Figure 3d). Immunohistochemically, the solid
mass was positive to epithelial membrane antigen (EMA)
and vimentin, but the perivascular proliferating spindle
cells showed no immunoreactive for EMA (Figure 4a and
Figure 1 Neuroimaging findings of lesion. (a) Preoperative axial T-1 weighted magnetic resonance imaging (MRI) revealed multifocal hypointense 
lesion localized in right frontoparietal lobe (white arrowed). (b) Sagittal MRI shows the well-circumscribed enhanced lesion extending from the super-
ficial cortex along the meninges into the depth of white matter.Chen et al. Diagnostic Pathology 2010, 5:39
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4b). Cytokeratin (CK), glial fibrillary acidic protein
(GFAP), CD34, Desmin, CD99 and S-100 were negative
in both components of lesion. MIB-1 index was high with
focally 20% in solid mass of lesion. However, there was
only up to 1% of MIB-1 index in perivascular spindle cells
(Figure 4c and 4d). Based on these findings, a histological
diagnosis of atypical meningioma (WHO grade II) associ-
ated with meningioangiomatosis was made.
During postoperative course, the patient developed a
transient mild left hemiparesis within 2 weeks after sur-
gery. When he was recovered from this condition, the
patient reported an improvement of his sensorimotor
problems, but slight numbness remained in his left lower
extremity. The patient was discharged home without
adjuvant radiotherapy or chemotherapy, and 11-month
follow-up was performed till the patient was lost to be
contacted. Follow-up MRI did not show any residual
lesion 3 months after surgery, and neither tumor recur-
rence nor seizure was found during this period of postop-
erative follow-up.
Meningioangiomatosis is a rare malformative or hama-
rtomatous lesion involved in meninges and cortex. It was
first described in 1915 by Bassoe and Nuzum as an inci-
dental autopsy finding in a boy with NF-2 [15]. In 1937,
Worster-Drought et al reported a similar case and named
it as "meningioangiomatosis" because the researchers
considered it was a "forme fruste" of NF [16]. Although
meningioangiomatosis was originally described in associ-
ation with NF-2, the recent study by Omeis et al [17] has
been revealed that meningioangiomatosis occurred more
frequently in sporadic form and only 14 cases (14%) of the
100 reported cases are associated with NF. Similarly,
Takeshima et al also observed this association in only 25%
of patients with meningioangiomatosis, whereas the
other 75% patients occurred only sporadically [18].
The pathogenesis of meningioangiomatosis remains
unclear, it has been debated whether the biological nature
is a hamartoma or a neoplasm. For a long time, meningio-
angiomatosis was considered as a harmartomatous lesion
with degenerative change [15]. Other main hypotheses of
meningioangiomatosis include cortical vascular malfor-
mation [19,20] and direct invasion of the brain paren-
chyma by a leptomeningeal-based meningioma [4]. Some
studies revealed that loss of 22q12 (NF2 gene) in an each
case of meningioangiomatosis and meningioangiomato-
sis-associated meningioma indicated the possibility of
which meningioangiomatosis may be neoplastic in nature
[8,19]. However, recent large genetic series demonstrated
that there was no NF2 gene mutation either in sporadic
or NF2-associated meningioangiomatosis. These findings
support the hypothesis of hamartomatous nature of men-
ingioangiomatosis [21,22]. In our case, we found the
MIB-1 index was consistently higher in the meningioma
component rather than meningioangiomatosis compo-
nent, and there were lack of EMA-positive cells in the
proliferative perivascular areas in meningioangiomatosis
component. These observations suggest that meningio-
angiomatosis had distinct histological and biological fea-
tures to meningioma. Regardless its etiology, we consider
meningioangiomatosis should be best categorized as a
hamartomatous or malformative lesion rather than a neo-
plasm in nature.
Meningioangiomatosis has rarely been reported to
coexist with meningiomas. To our knowledge, only 19
cases of meningioma together with meningioangiomato-
sis have been reported in English literature to date [2-14].
Among these patients, there was an obvious male ten-
dency of male to female ratio being approximately 3:1. It
contrasts to usual prevalence of meningioma in female
population (2:1 female/male ratio in intracranial menin-
giomas and 4:1 in spinal meningiomas). Meningioan-
giomatosis-associated meningiomas seem to occur
frequently in young patients with the mean age of 16.0
years (ranging from 9 months to 58 years old), although
other conventional meningiomas occur most commonly
in middle-aged or elderly patients. None of these patients
was associated with NF-2. The most common symptom
we observed in the literature review was seizure. Histo-
logically, most of meningiomas were frequent menin-
gioma variants, including 9 transitional meningiomas, 5
fibroblastic meningiomas, and 1 meningothelial menin-
gioma. There were only three rare variants recorded in
previous literatures: 1 atypical meningioma, 1 microcys-
tic meningioma and 1 "sclerosing variant". The last one
was not a widely known histological variant of menin-
gioma characterized by extensive collagen deposition
Figure 2 Gross examination of lesion. On macroscopical examina-
tion, the lesion was composed of grayish smaller tissue fragments of 
variable sizes and a whitish ovoid mass, measuring 3.0 cm in diameter. 
No necrosis, haemorrhage and gross calcification were found in the 
mass and other tissue fragments.Chen et al. Diagnostic Pathology 2010, 5:39
http://www.diagnosticpathology.org/content/5/1/39
Page 4 of 7
with focal cellular nests of meningothelial cells (Table 1).
Our case described a meningioangiomatosis-associated
meningioma occurred in a middle-aged man with atypi-
cal variant component and clear cell variant component,
both of which correspond to WHO grade II. To our
knowledge, this is the first case of a meningioangiomato-
sis-associated meningioma with clear cell variant compo-
nent. Like atypical meningioma, clear cell meningioma is
also an uncommon variant of meningioma. Mixed men-
ingiomas combined with different variant of menin-
gioma, including mixed atypical and clear cell
meningioma, have rarely been reported. However, they
are firstly found in meningioangiomatosis-associated
meningioma in our case. The findings in this case indi-
cate that meningioangiomatosis-associated meningioma
might be composed of any variants of meningioma either
in sole pattern or composite pattern.
The main differential diagnosis of meningioangiomato-
sis-associated meningioma to be considered on histopa-
thology is malignant meningioma with invasion of brain
parenchyma because infiltration of cortex by the perivas-
cular proliferating spindle cells and reactive gliosis some-
times may be erroneously interpreted as invasion of
brain. However, true parenchymal invasion is present
when neoplastic cells break through the pia mater to
involve the underlying cortex and encircle islands of
heavily gliotic tissue. In our case, meningioma compo-
nents of the lesion mixed atypical cells and clear cells
with hypercellularity, higher mitotic activity and higher
MIB-1 index which corresponded to WHO grade II; how-
ever, the fibroblast-like spindle cells disposed around the
blood vessels were bland appearance with lower prolifer-
ation index and lacking EMA expression. Therefore, we
did not regard the meningioangiomatosis component of
Figure 3 Histopathological findings of lesion.  (a) Photomicrographs showed that focal hypercellularity and atypia were noted in whitish mass with 
higher mitotic activity (white arrowed) and enlarged polymorphic nuclei (black arrowed). (b) In some area, the mass was composed of mainly clear 
cells with small round monomorphic nuclei and abundant clear cytoplasm resembling the histological feature of clear cell variant of meningioma. (c) 
The adjacent brain parenchyma to the mass and other removed smaller grayish lesion revealed numerous abnormal small intracortical blood vessels, 
which were cuffed by meningothelial or fibroblasts-like spindle cells with bland nuclei and elongated cytoplasm. (d) The gradual transition from 
perivascular proliferation of spindle cells to the mass of the meningioma could be observed. (a & b, H&E staining with original magnification of 400×; 
c, H&E staining with original magnification of 200×; d, H&E staining with original magnification of 100×).Chen et al. Diagnostic Pathology 2010, 5:39
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the lesion as the brain invasion by atypical or clear cell
meningioma because high level of MIB-1 index is known
t o  be  d e t e c t e d  i n  m e n i n gi o m as  o f  b r a i n  i n v a s i o n  [ 2 3 ] .
These findings suggest encircled gliotic cortical tissue is
not true invasion but a condition simulated by meningio-
angiomatosis. Cases of meningioangiomatosis with men-
ingioma usually had a favourable outcome after surgical
resection. In previously reported cases, only one case was
dead due to operative complication [2], and another one
had recurrence after surgery [9]. In our case, a follow-up
period of 11 months was performed but the patient did
not show any sign of tumor recurrence or seizure. In con-
trast to the pervious cases with conventional meningioma
variants, ours presented a more aggressive meningioma
variant corresponding to WHO grade II. Further investi-
gation with more cases and longer follow-up data need to
be performed to clarify whether or not aggressive variant
of meningioma might result in a worse prognosis of men-
ingioangiomatosis-associated meningioma.
Conclusion
We reported a rare case of meningioangiomatosis-associ-
ated meningioma with atypical and clear cell meningioma
variants occurring in frontoparietal lobe of a middle-aged
man. In contrast to conventional meningiomas, menin-
gioangiomatosis-associated meningioma is more likely to
occur in younger males, and any variants of meningioma
might present in this lesion with either sole pattern or
composite pattern. Although meningioangiomatosis is a
benign hamartomatous or malformative lesion, it may be
erroneously interpreted as brain invasion when it uncom-
monly co-existed with meningioma. The relationship
between the prognosis and meningioangiomatosis-asso-
ciated aggressive meningioma remains unclear. The
Figure 4 Immunohistochemical staining of lesion. Immunohistochemical staining for EMA demostrated the neoplastic cells were focally positive 
in atypical meningioma area (a), but lack of immunoreactivity in the spindle cells of meningioangiomatosis area (b). Higher cellular proliferation was 
observed in the atypical meningioma area with approximately 20% of MIB-1 index (c), but lower MIB-1 index of up to 1% was detected in the spindle 
cells of meningioangiomatosis area (d). (a-d, immunohistochemical staining with original magnification of 400×)Chen et al. Diagnostic Pathology 2010, 5:39
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investigations of a longer follow-up period and more
cases would help to better clarify the biological character-
istics and clinical outcome of this rare but distinct lesion.
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